Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial-Reference-Cited by-同舟云学术

Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

Published:2022-10-17 Issue:11 Volume:28 Page:2424-2435
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Gunst Jesper D.^ORCID,Pahus Marie H.,Rosás-Umbert Miriam^ORCID,Lu I-Na,Benfield Thomas^ORCID,Nielsen Henrik,Johansen Isik S.,Mohey Rajesh,Østergaard Lars,Klastrup Vibeke,Khan Maryam,Schleimann Mariane H.,Olesen Rikke,Støvring Henrik,Denton Paul W.^ORCID,Kinloch Natalie N.,Copertino Dennis C.^ORCID,Ward Adam R.^ORCID,Alberto Winiffer D. Conce,Nielsen Silke D.,Puertas Maria C.^ORCID,Ramos Victor,Reeves Jacqueline D.,Petropoulos Christos J.^ORCID,Martinez-Picado Javier^ORCID,Brumme Zabrina L.^ORCID,Jones R. Brad^ORCID,Fox Julie,Tolstrup Martin,Nussenzweig Michel C.^ORCID,Caskey Marina,Fidler Sarah,Søgaard Ole S.^ORCID

Funder

Sundhed og Sygdom, Det Frie Forskningsråd

Aarhus Universitet

The Danish Regions’ Medicine and Treatment Fund

Gouvernement du Canada | Canadian Institutes of Health Research

Michael Smith Foundation for Health Research

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-022-02023-7.pdf